| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medulloblastoma | 65 | 2024 | 678 | 7.670 |
Why?
|
| Cerebellar Neoplasms | 43 | 2024 | 586 | 5.630 |
Why?
|
| Neurology | 10 | 2024 | 780 | 1.940 |
Why?
|
| Brain Neoplasms | 34 | 2020 | 9031 | 1.030 |
Why?
|
| Craniopharyngioma | 9 | 2012 | 277 | 0.970 |
Why?
|
| Hedgehog Proteins | 16 | 2024 | 768 | 0.810 |
Why?
|
| Pediatrics | 6 | 2016 | 3589 | 0.620 |
Why?
|
| Ependymoma | 5 | 2015 | 320 | 0.610 |
Why?
|
| Astrocytoma | 11 | 2013 | 775 | 0.600 |
Why?
|
| Nervous System Diseases | 4 | 2023 | 1667 | 0.590 |
Why?
|
| Neuroectodermal Tumors, Primitive | 5 | 2014 | 136 | 0.530 |
Why?
|
| Gene Expression Profiling | 23 | 2024 | 9420 | 0.510 |
Why?
|
| Cell Tracking | 1 | 2016 | 139 | 0.510 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2014 | 350 | 0.490 |
Why?
|
| Child | 75 | 2023 | 80157 | 0.490 |
Why?
|
| Central Nervous System Neoplasms | 3 | 2015 | 916 | 0.450 |
Why?
|
| Receptors, Nerve Growth Factor | 7 | 2002 | 198 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 20 | 2019 | 8553 | 0.440 |
Why?
|
| Disabled Children | 1 | 2016 | 251 | 0.430 |
Why?
|
| Genomics | 12 | 2019 | 5821 | 0.420 |
Why?
|
| Bullying | 1 | 2016 | 232 | 0.410 |
Why?
|
| Transcription Factors | 13 | 2017 | 12130 | 0.400 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2011 | 3779 | 0.400 |
Why?
|
| Crime Victims | 1 | 2016 | 347 | 0.380 |
Why?
|
| DNA-Binding Proteins | 13 | 2016 | 9610 | 0.380 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2011 | 62 | 0.380 |
Why?
|
| Epigenesis, Genetic | 8 | 2020 | 3801 | 0.370 |
Why?
|
| Cell Lineage | 5 | 2019 | 2557 | 0.370 |
Why?
|
| MicroRNAs | 8 | 2019 | 3816 | 0.360 |
Why?
|
| Internship and Residency | 2 | 2023 | 5882 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-myc | 7 | 2021 | 988 | 0.350 |
Why?
|
| Signal Transduction | 22 | 2019 | 23447 | 0.340 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2013 | 727 | 0.340 |
Why?
|
| Receptors, GABA-A | 1 | 2014 | 623 | 0.340 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2010 | 75 | 0.340 |
Why?
|
| Apoptosis | 13 | 2017 | 9491 | 0.340 |
Why?
|
| Intracellular Fluid | 1 | 2009 | 201 | 0.330 |
Why?
|
| Wnt Proteins | 10 | 2017 | 718 | 0.330 |
Why?
|
| Mutation | 19 | 2024 | 30054 | 0.320 |
Why?
|
| Pinealoma | 2 | 2019 | 52 | 0.320 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 491 | 0.310 |
Why?
|
| Child, Preschool | 46 | 2021 | 42231 | 0.300 |
Why?
|
| Tumor Suppressor Protein p53 | 9 | 2017 | 2918 | 0.300 |
Why?
|
| Humans | 146 | 2024 | 761578 | 0.300 |
Why?
|
| Rhabdoid Tumor | 8 | 2016 | 210 | 0.290 |
Why?
|
| Complementary Therapies | 1 | 2011 | 486 | 0.290 |
Why?
|
| Nerve Growth Factors | 5 | 1999 | 564 | 0.290 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2009 | 196 | 0.280 |
Why?
|
| Membrane Proteins | 6 | 2014 | 7859 | 0.280 |
Why?
|
| Neuroglia | 4 | 2019 | 956 | 0.280 |
Why?
|
| Pituitary Neoplasms | 6 | 2010 | 1324 | 0.280 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 600 | 0.270 |
Why?
|
| Radiotherapy | 5 | 2014 | 1499 | 0.270 |
Why?
|
| Pineal Gland | 3 | 2019 | 158 | 0.270 |
Why?
|
| Cerebellum | 8 | 2024 | 1501 | 0.270 |
Why?
|
| Neurosciences | 1 | 2011 | 367 | 0.270 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 1860 | 0.270 |
Why?
|
| Developmental Disabilities | 3 | 2019 | 1509 | 0.260 |
Why?
|
| Genes, p53 | 4 | 2013 | 712 | 0.260 |
Why?
|
| Behavior Therapy | 1 | 2011 | 879 | 0.260 |
Why?
|
| Child Behavior | 1 | 2011 | 847 | 0.260 |
Why?
|
| Plant Poisoning | 1 | 2005 | 13 | 0.260 |
Why?
|
| Receptors, Notch | 1 | 2010 | 744 | 0.250 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2017 | 2805 | 0.250 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 1999 | 1626 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2005 | 66 | 0.250 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2019 | 2827 | 0.240 |
Why?
|
| Down-Regulation | 3 | 2012 | 2919 | 0.240 |
Why?
|
| Prognosis | 22 | 2021 | 29629 | 0.240 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 490 | 0.240 |
Why?
|
| Wallerian Degeneration | 3 | 2008 | 68 | 0.230 |
Why?
|
| Ganglioglioma | 1 | 2003 | 36 | 0.220 |
Why?
|
| Melatonin | 1 | 2009 | 669 | 0.220 |
Why?
|
| Hypothalamic Diseases | 1 | 2005 | 134 | 0.220 |
Why?
|
| Moyamoya Disease | 1 | 2007 | 265 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 2 | 2017 | 170 | 0.220 |
Why?
|
| Brain Abscess | 1 | 2004 | 120 | 0.220 |
Why?
|
| Education, Medical, Graduate | 2 | 2016 | 2373 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 1899 | 0.210 |
Why?
|
| Myoclonus | 1 | 2003 | 107 | 0.210 |
Why?
|
| Age Factors | 5 | 2019 | 18398 | 0.210 |
Why?
|
| Adolescent | 43 | 2021 | 88323 | 0.210 |
Why?
|
| Receptor, trkC | 6 | 2005 | 63 | 0.210 |
Why?
|
| Histone Demethylases | 2 | 2024 | 323 | 0.210 |
Why?
|
| Athletic Injuries | 1 | 2012 | 1216 | 0.200 |
Why?
|
| Cell Proliferation | 10 | 2021 | 10451 | 0.200 |
Why?
|
| Embryo, Mammalian | 3 | 2024 | 1674 | 0.200 |
Why?
|
| Cell Line, Tumor | 19 | 2019 | 16990 | 0.200 |
Why?
|
| Growth Substances | 2 | 2003 | 768 | 0.200 |
Why?
|
| Antineoplastic Agents | 7 | 2021 | 13642 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2012 | 3612 | 0.190 |
Why?
|
| Polyomavirus | 1 | 2002 | 234 | 0.190 |
Why?
|
| Radiation Injuries | 3 | 2007 | 1189 | 0.190 |
Why?
|
| Brain Concussion | 1 | 2012 | 1404 | 0.190 |
Why?
|
| Postoperative Complications | 8 | 2009 | 15633 | 0.190 |
Why?
|
| Survivors | 2 | 2012 | 2371 | 0.190 |
Why?
|
| Infant | 26 | 2020 | 36193 | 0.190 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2022 | 114 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2018 | 17904 | 0.180 |
Why?
|
| Genome, Human | 4 | 2017 | 4425 | 0.180 |
Why?
|
| Akinetic Mutism | 1 | 2000 | 11 | 0.180 |
Why?
|
| Polyomavirus Infections | 1 | 2002 | 194 | 0.170 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 24 | 0.170 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2018 | 506 | 0.160 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 438 | 0.160 |
Why?
|
| Medical Oncology | 1 | 2011 | 2321 | 0.160 |
Why?
|
| Chromosome Aberrations | 4 | 2012 | 1768 | 0.160 |
Why?
|
| Genetic Testing | 3 | 2023 | 3537 | 0.160 |
Why?
|
| Cannabis | 1 | 2005 | 441 | 0.160 |
Why?
|
| Embryonic Development | 1 | 2024 | 721 | 0.160 |
Why?
|
| Mice | 40 | 2024 | 81539 | 0.160 |
Why?
|
| Seizures | 3 | 2021 | 2957 | 0.160 |
Why?
|
| Single-Cell Analysis | 3 | 2019 | 2451 | 0.160 |
Why?
|
| Memory Disorders | 2 | 2006 | 1199 | 0.150 |
Why?
|
| Animals | 49 | 2024 | 168475 | 0.150 |
Why?
|
| Germinoma | 1 | 1999 | 132 | 0.150 |
Why?
|
| Glutathione | 1 | 2021 | 583 | 0.150 |
Why?
|
| DNA Methylation | 7 | 2018 | 4399 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2019 | 9281 | 0.150 |
Why?
|
| Syncope | 1 | 2021 | 427 | 0.150 |
Why?
|
| Carboplatin | 1 | 2021 | 794 | 0.150 |
Why?
|
| Nervous System Malformations | 1 | 2000 | 244 | 0.150 |
Why?
|
| Tubulin | 2 | 2013 | 693 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1136 | 0.150 |
Why?
|
| Schwann Cells | 3 | 2008 | 197 | 0.150 |
Why?
|
| Gene Dosage | 4 | 2011 | 1218 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 6 | 2017 | 5790 | 0.140 |
Why?
|
| Neurotrophin 3 | 4 | 2005 | 61 | 0.140 |
Why?
|
| Otx Transcription Factors | 1 | 2017 | 42 | 0.140 |
Why?
|
| Academies and Institutes | 1 | 2019 | 318 | 0.140 |
Why?
|
| Germ-Line Mutation | 2 | 2018 | 1858 | 0.140 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1745 | 0.140 |
Why?
|
| Proto-Oncogenes | 1 | 1997 | 321 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2023 | 1742 | 0.140 |
Why?
|
| Spasms, Infantile | 1 | 2020 | 298 | 0.130 |
Why?
|
| Male | 61 | 2021 | 360841 | 0.130 |
Why?
|
| Genomic Instability | 2 | 2012 | 709 | 0.130 |
Why?
|
| Neoplasm, Residual | 1 | 2021 | 1008 | 0.130 |
Why?
|
| Standard of Care | 1 | 2020 | 551 | 0.130 |
Why?
|
| Parasympathetic Nervous System | 1 | 1996 | 142 | 0.130 |
Why?
|
| Choroid Plexus Neoplasms | 2 | 2006 | 38 | 0.130 |
Why?
|
| Sleep | 2 | 2009 | 4768 | 0.130 |
Why?
|
| DNA Mutational Analysis | 4 | 2018 | 4111 | 0.130 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2016 | 132 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7391 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2011 | 4793 | 0.120 |
Why?
|
| DNA, Viral | 1 | 2002 | 2202 | 0.120 |
Why?
|
| Central Nervous System | 2 | 2000 | 1336 | 0.120 |
Why?
|
| Sciatic Nerve | 2 | 2002 | 617 | 0.120 |
Why?
|
| Neoplasms | 6 | 2023 | 22172 | 0.120 |
Why?
|
| Drug Design | 2 | 2012 | 1048 | 0.120 |
Why?
|
| Diagnosis, Differential | 8 | 2021 | 12973 | 0.120 |
Why?
|
| Neurons | 8 | 2019 | 9463 | 0.120 |
Why?
|
| Female | 56 | 2021 | 392688 | 0.120 |
Why?
|
| RNA-Binding Proteins | 2 | 2014 | 1898 | 0.120 |
Why?
|
| Nuclear Proteins | 8 | 2018 | 5799 | 0.110 |
Why?
|
| Chromatin | 4 | 2024 | 2961 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 1351 | 0.110 |
Why?
|
| Receptor, trkB | 2 | 2013 | 124 | 0.110 |
Why?
|
| Survival Analysis | 8 | 2019 | 10090 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 1974 | 0.110 |
Why?
|
| Headache | 1 | 2001 | 1256 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 1363 | 0.110 |
Why?
|
| Phenotype | 9 | 2023 | 16592 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 5 | 2012 | 4415 | 0.110 |
Why?
|
| Hepatoblastoma | 1 | 2013 | 90 | 0.110 |
Why?
|
| Antigens, Neoplasm | 3 | 2010 | 1993 | 0.110 |
Why?
|
| International Agencies | 1 | 2013 | 243 | 0.110 |
Why?
|
| Mobius Syndrome | 1 | 2013 | 41 | 0.110 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2013 | 100 | 0.100 |
Why?
|
| Adult | 33 | 2024 | 221200 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2014 | 195 | 0.100 |
Why?
|
| Cell Movement | 2 | 2017 | 5205 | 0.100 |
Why?
|
| Olfactory Bulb | 2 | 1992 | 198 | 0.100 |
Why?
|
| Glioma | 5 | 2013 | 3455 | 0.100 |
Why?
|
| Neuropsychological Tests | 4 | 2006 | 7054 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 2898 | 0.100 |
Why?
|
| Genomic Structural Variation | 1 | 2012 | 68 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 634 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 257 | 0.100 |
Why?
|
| Kallmann Syndrome | 1 | 2013 | 139 | 0.100 |
Why?
|
| RNA, Neoplasm | 2 | 2010 | 750 | 0.100 |
Why?
|
| Teratoma | 2 | 2005 | 404 | 0.100 |
Why?
|
| DNA Copy Number Variations | 4 | 2019 | 2020 | 0.100 |
Why?
|
| Cell Cycle | 5 | 2017 | 2932 | 0.100 |
Why?
|
| Telomerase | 2 | 2014 | 745 | 0.100 |
Why?
|
| Lithium | 1 | 2014 | 596 | 0.100 |
Why?
|
| Vomiting | 2 | 2013 | 651 | 0.090 |
Why?
|
| Developmental Biology | 1 | 2012 | 79 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 8 | 2013 | 6132 | 0.090 |
Why?
|
| Models, Genetic | 3 | 2018 | 3442 | 0.090 |
Why?
|
| DNA Fingerprinting | 1 | 2011 | 114 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4576 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2012 | 322 | 0.090 |
Why?
|
| Young Adult | 16 | 2021 | 59254 | 0.090 |
Why?
|
| Wilms Tumor | 1 | 2013 | 379 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 2 | 2010 | 1705 | 0.090 |
Why?
|
| Gene Amplification | 3 | 2010 | 1089 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2012 | 418 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 318 | 0.090 |
Why?
|
| Neurosurgical Procedures | 3 | 2009 | 2072 | 0.090 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 495 | 0.090 |
Why?
|
| Computational Biology | 4 | 2016 | 3517 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2020 | 1906 | 0.090 |
Why?
|
| Peer Group | 1 | 2016 | 692 | 0.090 |
Why?
|
| Secretory Vesicles | 1 | 2011 | 128 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2013 | 4514 | 0.090 |
Why?
|
| Models, Biological | 4 | 2016 | 9469 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2012 | 682 | 0.080 |
Why?
|
| Retroelements | 1 | 2011 | 163 | 0.080 |
Why?
|
| RNA Precursors | 1 | 2011 | 212 | 0.080 |
Why?
|
| Receptors, Cell Surface | 6 | 2014 | 2822 | 0.080 |
Why?
|
| Transfection | 5 | 2017 | 5774 | 0.080 |
Why?
|
| CpG Islands | 1 | 2014 | 1230 | 0.080 |
Why?
|
| Meningitis | 1 | 1990 | 217 | 0.080 |
Why?
|
| Ganglia, Parasympathetic | 1 | 1988 | 18 | 0.080 |
Why?
|
| Brain-Derived Neurotrophic Factor | 6 | 2002 | 602 | 0.080 |
Why?
|
| Nerve Regeneration | 2 | 2008 | 795 | 0.080 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2009 | 140 | 0.080 |
Why?
|
| Neuroimmunomodulation | 1 | 2010 | 182 | 0.080 |
Why?
|
| Immunohistochemistry | 7 | 2012 | 11076 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1505 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 368 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 2510 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 1062 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2023 | 6567 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1739 | 0.080 |
Why?
|
| Cranial Irradiation | 3 | 2003 | 390 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2001 | 3242 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3605 | 0.070 |
Why?
|
| beta Catenin | 4 | 2014 | 1040 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2007 | 882 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2020 | 36426 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2007 | 638 | 0.070 |
Why?
|
| Chromosomes, Mammalian | 1 | 2008 | 147 | 0.070 |
Why?
|
| Axons | 3 | 2010 | 1674 | 0.070 |
Why?
|
| Mice, Nude | 4 | 2016 | 3614 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2014 | 5305 | 0.070 |
Why?
|
| Hypopituitarism | 1 | 2009 | 250 | 0.070 |
Why?
|
| Circle of Willis | 1 | 2007 | 78 | 0.070 |
Why?
|
| Receptor, erbB-2 | 1 | 1997 | 2557 | 0.070 |
Why?
|
| Risk Factors | 10 | 2019 | 74212 | 0.070 |
Why?
|
| Optic Chiasm | 1 | 2007 | 91 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 489 | 0.070 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2006 | 39 | 0.070 |
Why?
|
| Myelitis, Transverse | 1 | 2006 | 40 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 1252 | 0.070 |
Why?
|
| Repressor Proteins | 3 | 2014 | 2986 | 0.070 |
Why?
|
| Cognition | 1 | 2024 | 6992 | 0.070 |
Why?
|
| Phototherapy | 1 | 2009 | 368 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2010 | 5036 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 1612 | 0.070 |
Why?
|
| Phosphorylation | 4 | 2016 | 8321 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2014 | 384 | 0.060 |
Why?
|
| Emaciation | 1 | 2005 | 5 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2010 | 1069 | 0.060 |
Why?
|
| Hypothalamic Neoplasms | 1 | 2005 | 21 | 0.060 |
Why?
|
| Diencephalon | 1 | 2005 | 54 | 0.060 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2005 | 103 | 0.060 |
Why?
|
| Zebrafish | 1 | 2016 | 3007 | 0.060 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 15266 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 449 | 0.060 |
Why?
|
| Multigene Family | 3 | 2014 | 1076 | 0.060 |
Why?
|
| Oncogenes | 2 | 2023 | 1222 | 0.060 |
Why?
|
| Neoplasm Proteins | 3 | 2012 | 3617 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 2418 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 2226 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2006 | 453 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2013 | 12794 | 0.060 |
Why?
|
| Failure to Thrive | 1 | 2005 | 140 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5672 | 0.060 |
Why?
|
| Tremor | 1 | 2005 | 191 | 0.060 |
Why?
|
| Microarray Analysis | 3 | 2012 | 750 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11742 | 0.060 |
Why?
|
| Ribosomal Proteins | 1 | 2006 | 371 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 18255 | 0.060 |
Why?
|
| History, 20th Century | 2 | 2019 | 2767 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2014 | 2626 | 0.060 |
Why?
|
| Pheochromocytoma | 2 | 2008 | 328 | 0.060 |
Why?
|
| Streptococcus | 1 | 2004 | 198 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 3713 | 0.060 |
Why?
|
| Cerebellar Nuclei | 1 | 2003 | 51 | 0.060 |
Why?
|
| Etanidazole | 1 | 2003 | 22 | 0.060 |
Why?
|
| DNA, Circular | 1 | 2023 | 97 | 0.050 |
Why?
|
| Dysarthria | 1 | 2003 | 58 | 0.050 |
Why?
|
| Long QT Syndrome | 1 | 2008 | 467 | 0.050 |
Why?
|
| Cyclin D1 | 2 | 2008 | 451 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2013 | 2856 | 0.050 |
Why?
|
| Optic Nerve Glioma | 1 | 2003 | 32 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1651 | 0.050 |
Why?
|
| Pyridines | 3 | 2016 | 2875 | 0.050 |
Why?
|
| Cell Survival | 4 | 2017 | 5791 | 0.050 |
Why?
|
| Ataxia | 1 | 2005 | 306 | 0.050 |
Why?
|
| Cohort Studies | 9 | 2019 | 41493 | 0.050 |
Why?
|
| Molecular Biology | 1 | 2006 | 576 | 0.050 |
Why?
|
| Receptors, Growth Factor | 1 | 2003 | 326 | 0.050 |
Why?
|
| Boston | 2 | 2007 | 9326 | 0.050 |
Why?
|
| Mice, Inbred Strains | 3 | 1996 | 1762 | 0.050 |
Why?
|
| Cytogenetics | 2 | 2014 | 198 | 0.050 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2003 | 228 | 0.050 |
Why?
|
| Ganglia, Spinal | 3 | 2000 | 526 | 0.050 |
Why?
|
| Meningeal Neoplasms | 1 | 2011 | 1248 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 1990 | 1391 | 0.050 |
Why?
|
| Cell Migration Assays | 2 | 2012 | 22 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
| Epilepsy | 2 | 2015 | 3290 | 0.050 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 3 | 1999 | 36 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 687 | 0.050 |
Why?
|
| Flavonoids | 1 | 2005 | 445 | 0.050 |
Why?
|
| Kv1.1 Potassium Channel | 2 | 2012 | 30 | 0.050 |
Why?
|
| Cerebellar Ataxia | 1 | 2003 | 150 | 0.050 |
Why?
|
| Radiosurgery | 3 | 2005 | 1342 | 0.050 |
Why?
|
| JC Virus | 1 | 2002 | 87 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 11904 | 0.050 |
Why?
|
| Neurofibromatosis 1 | 1 | 2007 | 561 | 0.050 |
Why?
|
| Consensus | 1 | 2011 | 3123 | 0.050 |
Why?
|
| Simian virus 40 | 1 | 2002 | 291 | 0.050 |
Why?
|
| Dyneins | 1 | 2002 | 124 | 0.050 |
Why?
|
| Retrospective Studies | 12 | 2023 | 80646 | 0.050 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2002 | 257 | 0.050 |
Why?
|
| Base Sequence | 5 | 2014 | 12441 | 0.050 |
Why?
|
| BK Virus | 1 | 2002 | 123 | 0.050 |
Why?
|
| Axonal Transport | 2 | 2002 | 178 | 0.050 |
Why?
|
| Follow-Up Studies | 10 | 2012 | 39107 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2010 | 1699 | 0.050 |
Why?
|
| Histones | 4 | 2014 | 2580 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2014 | 504 | 0.050 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2003 | 350 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 2872 | 0.050 |
Why?
|
| Proteomics | 3 | 2024 | 3848 | 0.050 |
Why?
|
| Brain Stem Neoplasms | 1 | 2003 | 190 | 0.050 |
Why?
|
| Syncope, Vasovagal | 1 | 2021 | 38 | 0.050 |
Why?
|
| Cisplatin | 3 | 2013 | 1652 | 0.050 |
Why?
|
| Genes, Switch | 1 | 2000 | 48 | 0.040 |
Why?
|
| Brain | 7 | 2023 | 27121 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2013 | 1609 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2005 | 642 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8656 | 0.040 |
Why?
|
| 3T3 Cells | 3 | 2013 | 1085 | 0.040 |
Why?
|
| Receptor, trkA | 2 | 1997 | 159 | 0.040 |
Why?
|
| Vigabatrin | 1 | 2020 | 88 | 0.040 |
Why?
|
| Heterozygote | 2 | 2003 | 2787 | 0.040 |
Why?
|
| Neurites | 2 | 1999 | 391 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2008 | 1555 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2013 | 945 | 0.040 |
Why?
|
| Paraganglioma | 1 | 2001 | 142 | 0.040 |
Why?
|
| Mice, Inbred NOD | 2 | 2014 | 1827 | 0.040 |
Why?
|
| Piperazines | 2 | 2016 | 2523 | 0.040 |
Why?
|
| Research Personnel | 1 | 2024 | 588 | 0.040 |
Why?
|
| Meningitis, Bacterial | 1 | 2001 | 221 | 0.040 |
Why?
|
| Prednisolone | 1 | 2020 | 326 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 1999 | 2910 | 0.040 |
Why?
|
| Imidazoles | 1 | 2005 | 1180 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12059 | 0.040 |
Why?
|
| Stimulation, Chemical | 1 | 1999 | 306 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 3889 | 0.040 |
Why?
|
| Polyploidy | 2 | 2012 | 119 | 0.040 |
Why?
|
| Neurologic Examination | 3 | 2001 | 916 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 420 | 0.040 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1999 | 71 | 0.040 |
Why?
|
| Stem Cells | 3 | 2010 | 3524 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 3449 | 0.040 |
Why?
|
| Benzodiazepines | 2 | 2016 | 1132 | 0.040 |
Why?
|
| Unconsciousness | 1 | 2021 | 250 | 0.040 |
Why?
|
| Serpins | 1 | 2000 | 247 | 0.040 |
Why?
|
| Methylation | 2 | 2012 | 1084 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2012 | 855 | 0.040 |
Why?
|
| Cell Division | 2 | 2003 | 4465 | 0.040 |
Why?
|
| Basal Ganglia Diseases | 1 | 1999 | 145 | 0.040 |
Why?
|
| Hemiplegia | 1 | 1999 | 136 | 0.040 |
Why?
|
| Genes, myc | 2 | 2012 | 390 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2001 | 20569 | 0.040 |
Why?
|
| Cerebral Aqueduct | 1 | 1978 | 40 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2020 | 618 | 0.040 |
Why?
|
| Survival Rate | 4 | 2019 | 12725 | 0.040 |
Why?
|
| Obesity, Morbid | 1 | 2009 | 1277 | 0.040 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2018 | 112 | 0.040 |
Why?
|
| Isoflavones | 1 | 1999 | 136 | 0.040 |
Why?
|
| Raphe Nuclei | 1 | 1978 | 103 | 0.040 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1998 | 85 | 0.040 |
Why?
|
| Videoconferencing | 1 | 2020 | 203 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2005 | 2665 | 0.040 |
Why?
|
| Pedigree | 2 | 2018 | 4542 | 0.040 |
Why?
|
| Causality | 1 | 2004 | 1242 | 0.040 |
Why?
|
| Growth | 1 | 2000 | 365 | 0.040 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 888 | 0.040 |
Why?
|
| Chromosomes, Human | 2 | 2012 | 441 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 1600 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2021 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4317 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 2576 | 0.040 |
Why?
|
| Heredity | 1 | 2018 | 148 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2013 | 5439 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 20099 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2024 | 863 | 0.040 |
Why?
|
| Mice, Knockout | 4 | 2024 | 14417 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 1997 | 311 | 0.040 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 1745 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 205 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 2865 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 9542 | 0.030 |
Why?
|
| DNA Helicases | 2 | 2012 | 851 | 0.030 |
Why?
|
| International Cooperation | 2 | 2014 | 1422 | 0.030 |
Why?
|
| Mutation, Missense | 3 | 2013 | 2571 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2019 | 3514 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 1997 | 456 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2011 | 15936 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2013 | 6484 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 2421 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2457 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1999 | 586 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 404 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 1115 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2010 | 1646 | 0.030 |
Why?
|
| Disease Progression | 5 | 2005 | 13510 | 0.030 |
Why?
|
| United States | 4 | 2024 | 72335 | 0.030 |
Why?
|
| Europe | 2 | 2013 | 3420 | 0.030 |
Why?
|
| Combined Modality Therapy | 6 | 2010 | 8528 | 0.030 |
Why?
|
| Gene Silencing | 2 | 2014 | 1509 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 3792 | 0.030 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2001 | 732 | 0.030 |
Why?
|
| Rats | 6 | 2008 | 23741 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 1996 | 504 | 0.030 |
Why?
|
| Plant Extracts | 1 | 1999 | 497 | 0.030 |
Why?
|
| Transcription, Genetic | 4 | 2010 | 7593 | 0.030 |
Why?
|
| PC12 Cells | 2 | 2008 | 317 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 352 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1997 | 574 | 0.030 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 13446 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 12463 | 0.030 |
Why?
|
| Physicians | 1 | 2013 | 4591 | 0.030 |
Why?
|
| Prospective Studies | 6 | 2018 | 54423 | 0.030 |
Why?
|
| Cell Size | 1 | 1996 | 624 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 17635 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2001 | 1722 | 0.030 |
Why?
|
| Risk Assessment | 4 | 2014 | 23996 | 0.030 |
Why?
|
| Pituitary Irradiation | 1 | 1994 | 14 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2010 | 1900 | 0.030 |
Why?
|
| Memory | 1 | 2024 | 2193 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1068 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 2425 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2010 | 4142 | 0.030 |
Why?
|
| Morphine | 1 | 1978 | 657 | 0.030 |
Why?
|
| Incidence | 2 | 2015 | 21355 | 0.030 |
Why?
|
| Health Resources | 1 | 2020 | 935 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2014 | 81 | 0.030 |
Why?
|
| Atrophy | 1 | 1999 | 1633 | 0.030 |
Why?
|
| Arteries | 1 | 1999 | 1123 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2019 | 1176 | 0.030 |
Why?
|
| Carcinoma | 1 | 2005 | 2330 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2008 | 2677 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2013 | 93 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2013 | 352 | 0.030 |
Why?
|
| Time Factors | 4 | 2013 | 39970 | 0.030 |
Why?
|
| GABA Agonists | 1 | 2013 | 105 | 0.030 |
Why?
|
| Protein Transport | 2 | 2010 | 1967 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2014 | 287 | 0.030 |
Why?
|
| Tetraploidy | 1 | 2012 | 28 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2002 | 8181 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2019 | 1567 | 0.030 |
Why?
|
| Brain Stem | 1 | 1978 | 858 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3597 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2001 | 2495 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 410 | 0.030 |
Why?
|
| Cell Count | 1 | 1996 | 1835 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 655 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2011 | 1756 | 0.030 |
Why?
|
| Comorbidity | 1 | 2007 | 10508 | 0.030 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2012 | 43 | 0.030 |
Why?
|
| Comet Assay | 1 | 2012 | 75 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2020 | 1030 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 1860 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 550 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2013 | 367 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2012 | 138 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2020 | 26198 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2017 | 1154 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 2017 | 4937 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 473 | 0.020 |
Why?
|
| Risk | 1 | 2004 | 9610 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2006 | 3980 | 0.020 |
Why?
|
| Cell Line | 2 | 2013 | 15601 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 535 | 0.020 |
Why?
|
| Meningitis, Haemophilus | 1 | 1990 | 20 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2012 | 314 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1994 | 555 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 927 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2003 | 3028 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2011 | 207 | 0.020 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2010 | 74 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 2244 | 0.020 |
Why?
|
| Meningitis, Pneumococcal | 1 | 1990 | 43 | 0.020 |
Why?
|
| Menopause | 1 | 1999 | 1646 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2009 | 11530 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2014 | 3639 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2012 | 329 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2014 | 1463 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2011 | 426 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2016 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2012 | 590 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 14032 | 0.020 |
Why?
|
| Australia | 1 | 2013 | 1250 | 0.020 |
Why?
|
| Mitomycin | 1 | 2010 | 263 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 719 | 0.020 |
Why?
|
| Virus Replication | 1 | 1998 | 2435 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1998 | 2612 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 1578 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2011 | 664 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 469 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2012 | 350 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 2386 | 0.020 |
Why?
|
| Disease Management | 1 | 2020 | 2508 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 1271 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 1494 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2016 | 815 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 670 | 0.020 |
Why?
|
| Nomograms | 1 | 2011 | 230 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 714 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1992 | 2561 | 0.020 |
Why?
|
| Anxiety | 1 | 2024 | 4573 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2014 | 1007 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3597 | 0.020 |
Why?
|
| Phosphopeptides | 2 | 2002 | 240 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 1964 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2024 | 3429 | 0.020 |
Why?
|
| North America | 1 | 2012 | 1276 | 0.020 |
Why?
|
| Diploidy | 1 | 2008 | 132 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4125 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2011 | 803 | 0.020 |
Why?
|
| Proteome | 1 | 2018 | 1862 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5492 | 0.020 |
Why?
|
| G2 Phase | 1 | 2008 | 136 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 410 | 0.020 |
Why?
|
| NF-kappa B | 2 | 2012 | 2490 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2008 | 3094 | 0.020 |
Why?
|
| Cyclin D | 1 | 2008 | 72 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2016 | 1051 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2122 | 0.020 |
Why?
|
| Epigenomics | 1 | 2014 | 943 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2008 | 18966 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 81 | 0.020 |
Why?
|
| Japan | 1 | 2012 | 1378 | 0.020 |
Why?
|
| Lipids | 1 | 1999 | 3341 | 0.020 |
Why?
|
| Dendrites | 1 | 1990 | 475 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2011 | 1991 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2010 | 698 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 867 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2012 | 918 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2013 | 1141 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3306 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4740 | 0.020 |
Why?
|
| Etoposide | 1 | 2008 | 634 | 0.020 |
Why?
|
| Syndrome | 2 | 2005 | 3267 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 1380 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1263 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1393 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 2820 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1642 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 2477 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 1486 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 1302 | 0.020 |
Why?
|
| Acute Disease | 2 | 2001 | 7237 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 1999 | 502 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14665 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 2879 | 0.020 |
Why?
|
| Lysine | 1 | 2010 | 993 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3415 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2811 | 0.020 |
Why?
|
| Karyotyping | 1 | 2007 | 1171 | 0.020 |
Why?
|
| Cyclins | 1 | 2008 | 594 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 7406 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2005 | 1784 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 3968 | 0.020 |
Why?
|
| Polysomnography | 1 | 2012 | 1848 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2707 | 0.020 |
Why?
|
| Hyperkinesis | 1 | 2005 | 89 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2010 | 64684 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2018 | 8633 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2006 | 370 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 1964 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2022 | 4811 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2020 | 6237 | 0.010 |
Why?
|
| Neural Pathways | 2 | 1990 | 3060 | 0.010 |
Why?
|
| Fluorescent Dyes | 2 | 1992 | 1903 | 0.010 |
Why?
|
| Radiotherapy Dosage | 2 | 2005 | 2898 | 0.010 |
Why?
|
| Nystagmus, Pathologic | 1 | 2005 | 105 | 0.010 |
Why?
|
| Brain Damage, Chronic | 2 | 1995 | 267 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 2008 | 479 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2010 | 1264 | 0.010 |
Why?
|
| Aging | 3 | 2012 | 8711 | 0.010 |
Why?
|
| Microtubules | 1 | 2010 | 1074 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4671 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1995 | 2656 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8224 | 0.010 |
Why?
|
| Self-Assessment | 1 | 2006 | 397 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2192 | 0.010 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 2057 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 1992 | 9001 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1406 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2003 | 6845 | 0.010 |
Why?
|
| ROC Curve | 1 | 2011 | 3578 | 0.010 |
Why?
|
| Mass Screening | 1 | 2019 | 5428 | 0.010 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2005 | 263 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2011 | 2330 | 0.010 |
Why?
|
| Telemedicine | 1 | 2020 | 3052 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 184 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6241 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2002 | 107 | 0.010 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2002 | 73 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 317 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5336 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2008 | 952 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2011 | 6344 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2002 | 178 | 0.010 |
Why?
|
| Alleles | 1 | 2013 | 6864 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 3430 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2001 | 104 | 0.010 |
Why?
|
| Cell Communication | 1 | 1988 | 1657 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2005 | 1085 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 2003 | 6214 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 9177 | 0.010 |
Why?
|
| Synapses | 1 | 1990 | 1769 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2001 | 311 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 2001 | 145 | 0.010 |
Why?
|
| Mucin-1 | 1 | 2005 | 540 | 0.010 |
Why?
|
| HIV-1 | 1 | 1998 | 6863 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2003 | 823 | 0.010 |
Why?
|
| Time | 1 | 2001 | 546 | 0.010 |
Why?
|
| Cyclin E | 1 | 2000 | 156 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2008 | 1250 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4615 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2000 | 532 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2832 | 0.010 |
Why?
|
| Compliance | 1 | 1999 | 100 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2000 | 817 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2005 | 2927 | 0.010 |
Why?
|
| DNA Repair | 1 | 2008 | 2046 | 0.010 |
Why?
|
| Remission Induction | 1 | 2005 | 2397 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 12990 | 0.010 |
Why?
|
| Binding Sites | 2 | 1998 | 6056 | 0.010 |
Why?
|
| DNA Damage | 1 | 2008 | 2449 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 1130 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 1776 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1978 | 225 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 221 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3549 | 0.010 |
Why?
|
| Receptors, Opioid | 1 | 1978 | 145 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 1265 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2004 | 2601 | 0.010 |
Why?
|
| Benzamides | 1 | 2003 | 1370 | 0.010 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 1998 | 84 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1998 | 416 | 0.010 |
Why?
|
| Proteins | 1 | 2012 | 6032 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 1935 | 0.010 |
Why?
|
| Genome | 1 | 2005 | 1740 | 0.010 |
Why?
|
| Quality of Life | 1 | 2019 | 13367 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2005 | 1819 | 0.010 |
Why?
|
| Cytosol | 1 | 2000 | 888 | 0.010 |
Why?
|
| Celiac Disease | 1 | 2005 | 821 | 0.010 |
Why?
|
| Middle Aged | 5 | 2013 | 220917 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13255 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2000 | 754 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1997 | 361 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2000 | 774 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 1551 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 1998 | 740 | 0.010 |
Why?
|
| Proviruses | 1 | 1998 | 313 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2748 | 0.010 |
Why?
|
| Catalysis | 1 | 1997 | 774 | 0.010 |
Why?
|
| Naloxone | 1 | 1978 | 370 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 1995 | 152 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 4853 | 0.010 |
Why?
|
| Mitosis | 1 | 2000 | 1188 | 0.010 |
Why?
|
| Acetylation | 1 | 1997 | 1055 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 6377 | 0.010 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1995 | 135 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 6815 | 0.010 |
Why?
|
| Nociceptors | 1 | 1978 | 461 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 1978 | 590 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 1749 | 0.010 |
Why?
|
| Hypophysectomy | 1 | 1994 | 114 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1529 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 2180 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12690 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10194 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 7581 | 0.010 |
Why?
|
| Reference Values | 1 | 2000 | 4920 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1978 | 1047 | 0.010 |
Why?
|
| Psychometrics | 1 | 2001 | 3065 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 22173 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2002 | 4915 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3733 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2001 | 4243 | 0.010 |
Why?
|
| Craniotomy | 1 | 1995 | 741 | 0.010 |
Why?
|
| Alopecia | 1 | 1994 | 412 | 0.010 |
Why?
|
| Contrast Media | 1 | 2003 | 5307 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 12947 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2005 | 3615 | 0.010 |
Why?
|
| Antibodies | 1 | 1997 | 2418 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1998 | 2199 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4352 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2000 | 2020 | 0.000 |
Why?
|
| Glioblastoma | 1 | 2003 | 3482 | 0.000 |
Why?
|
| Microscopy | 1 | 1992 | 903 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1978 | 10766 | 0.000 |
Why?
|
| Head and Neck Neoplasms | 1 | 2000 | 2895 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15843 | 0.000 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 1994 | 1661 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1999 | 12341 | 0.000 |
Why?
|
| Membrane Glycoproteins | 1 | 1995 | 3701 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 13382 | 0.000 |
Why?
|
| Aged | 2 | 1999 | 169308 | 0.000 |
Why?
|